SUSQUEHANNA INTERNATIONAL GROUP, LLP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$6,183,432
-55.2%
242,013
-49.7%
0.00%
-66.7%
Q2 2023$13,789,143
+104.6%
480,793
+71.0%
0.00%
+50.0%
Q1 2023$6,738,015
+53.2%
281,102
+8.4%
0.00%
+100.0%
Q4 2022$4,397,185
-23.4%
259,268
-33.1%
0.00%0.0%
Q3 2022$5,744,000
-15.2%
387,547
-9.9%
0.00%
-66.7%
Q2 2022$6,772,000
-55.6%
430,202
-24.0%
0.00%0.0%
Q1 2022$15,265,000
-57.4%
566,202
-41.6%
0.00%
Q4 2021$35,868,000
+59.3%
969,188
+105.7%
0.00%
-100.0%
Q3 2021$22,513,000
+74.2%
471,172
+23.4%
0.00%0.0%
Q2 2021$12,921,000
-50.3%
381,832
-39.4%
0.00%
-25.0%
Q1 2021$26,004,000
-64.6%
629,630
-62.9%
0.00%
-33.3%
Q4 2020$73,544,000
+240.3%
1,695,322
+236.6%
0.01%
+50.0%
Q3 2020$21,610,000
-3.9%
503,715
+4.7%
0.00%
-20.0%
Q2 2020$22,485,000
+527.7%
481,062
+82.5%
0.01%
+400.0%
Q1 2020$3,582,000
+119.4%
263,555
+75.4%
0.00%
Q4 2019$1,633,000
+2.8%
150,289
-2.9%
0.00%
Q3 2019$1,589,000
+77.9%
154,760
+63.5%
0.00%
Q2 2019$893,00094,6530.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders